twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
6/2003
vol. 105
 
Share:
Share:
abstract:
Review article

New methods of therapy for ocular inflammatory autoimmune diseases

Agnieszka Kubicka-Trząska
1
,
Anetta Undas
2

  1. Z Katedry i Kliniki Okulistyki Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie
  2. Z II Katedry Chorób Wewnętrznych Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie
Online publish date: 2003/12/21
View full text Get citation
 
The authors review the current literature, regarding the efficacy and safety of new methods of therapy for ocular inflammatory autoimmune diseases: scleritis, pemphigoid and uveitis. Immunomodulation therapy is increasingly being used in various ocular inflammatory diseases, to avoid the effects of long-term steroid and immunosuppressive therapy and to induce remission in chronic disease. This therapy seems to be effective specially in treating resistant disease with relative safety. New approaches to therapy of intraocular inflammatory diseases will emphasize less immunosuppressive drugs and modification of the immune system with anti-MHC II, anti-adhesion molecules, anticytokines monoclonal antibodies, therapy with cytokines antagonists, intravenous immunoglobulin therapy, INF alpha therapy, antigen specific tolerancing therapy and gene therapy. Advances in the understanding of pathogenesis and in diagnostic techniques in various ocular inflammatory entities, will serve as a driving force for these new methods of treatment.
keywords:

cytokines, adhesion molecules, monoclonal antibodies, scleritis, ocular pemphigoid, uveitis

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.